News

Novosanis’ medical device Colli-Pee™ has been approved for sales in the US by FDA

Posted on 15/11/2016

Approval of Colli-Pee for commercial use in the US

First CE marked HPV test offering possibility to use first-void urine

Posted on 31/10/2016

Novosanis, a medical device company based in Wijnegem Belgium, together with GeneFirst, a molecular diagnostic company based in Oxfordshire UK, announced CE Marking and launch of...

Novosanis attending Life Sciences week and BioJapan

Posted on 12/10/2016

Novosanis will present its VAX-ID™ device platform during BioJapan

Novosanis participates in Belgian Royal Mission to Japan

Posted on 11/10/2016

Novosanis considers Japan as an important market due to its innovative vision towards healthcare and diagnostics.

You are here

Novosanis’ medical device Colli-Pee™ has been approved for sales in the US by FDA

First CE marked HPV test offering possibility to use first-void urine

Novosanis attending Life Sciences week and BioJapan

Novosanis participates in Belgian Royal Mission to Japan

Pages

novosanis